Scientists at the Institute for Stem Cell Research, of the University of Edinburgh show that mouse embryonic stem cells need the protein FGF4 to become competent to be converted into specialized cell types, such as brain or muscle cells.
These findings add to the growing body of knowledge that researchers all over the world are using to direct embryonic stem cells to become specific specialised cells – a fundamental requirement for using lab-grown cells to model disease, test the effects of new drugs and, potentially, treat disease and injury.
Embryonic stem cells have the unique ability to divide to produce both copies of themselves and other, more specialised, cell types. The process whereby embryonic stem cells commit to become specialised cells is still obscure.